Evidence map›Paper›PMID 37860779›Full record

ArticleFrontiers in reproductive health2023

Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women.

Kathleen E Hurwitz, Oluwaseyi O Isehunwa, Kayla R Hendrickson, Manjeetha Jaggernath, Yolandie Kriel, Patricia M Smith, Mxolisi Mathenjwa, Kara Bennett, Christina Psaros, Jared M Baeten and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in reproductive health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Kathleen E HurwitzDepartment of Epidemiology and Statistics, Target RWE, Durham, NC, United States.
Oluwaseyi O IsehunwaDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Kayla R HendricksonDepartment of Epidemiology and Statistics, Target RWE, Durham, NC, United States.
Manjeetha JaggernathMRU (Maternal, Adolescent and Child Health Research Unit), University of the Witwatersrand, Durban, South Africa.
Yolandie KrielMRU (Maternal, Adolescent and Child Health Research Unit), University of the Witwatersrand, Durban, South Africa.
Patricia M SmithDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Mxolisi MathenjwaDepartment of Epidemiology and Prevention, Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
Kara BennettDepartment of Epidemiology and Statistics, Target RWE, Durham, NC, United States.
Christina PsarosDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Jared M BaetenDepartment of Medicine, University of Washington, Seattle, WA, United States.
David R BangsbergVin University College of Health Sciences, Hanoi, Vietnam.
Jessica E HabererCenter for Global Health, Massachusetts General Hospital, Boston, MA, United States.
Jennifer A SmitMRU (Maternal, Adolescent and Child Health Research Unit), University of the Witwatersrand, Durban, South Africa.
Lynn T MatthewsDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Target (United States) · USUniversity of Alabama at Birmingham · USUniversity of the Witwatersrand · ZAHarvard University · USCentre for the AIDS Programme of Research in South Africa · ZAUniversity of Washington · USVinUniversity · VN

Funding

PrEP Uptake/Adherence to Reduce Periconception HIV Risk for South African WomenR01MH108412 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MATTHEWS, LYNN T · 2016 to 2020
$3.3M
Periconception HIV risk reduction for HIV-discordant couples in UgandaK23MH095655 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI MATTHEWS, LYNN T · 2011 to 2015
$854k
NIMH NIH HHS K23 MH095655NIMH NIH HHS R01 MH108412
6 · The paper itself

Abstract

Background: Daily, oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) as pre-exposure prophylaxis (PrEP) reduces HIV acquisition for African women. Adherence is key to efficacy and patterns of adherence can be highly variable in real-world settings. Using group-based trajectory modeling (GBTM), we sought to identify distinct patterns of periconception PrEP adherence and evaluate potential baseline predictors of such adherence trajectories. Methods: We conducted a single-arm longitudinal study for women aged 18-35 years living in Durban, South Africa with personal or partner plans for pregnancy with a partner with HIV or of unknown serostatus. Participants were offered safer conception counseling, including daily oral PrEP; women who initiated PrEP were given a bottle with an electronic pillcap that recorded when device opens. Weekly adherence to daily PrEP was modeled using GBTM with a censored normal outcome distribution as a function of weeks since PrEP initiation. The number and functional form of the adherence trajectory groups were primarily selected based on Bayesian information criteria (BIC) and confirmed by mean estimated probabilities of group membership. A multivariable version of the selected model assessed baseline predictors of membership in adherence trajectory groups. Results: Overall mean (95% CI) adherence to PrEP was 63% (60%, 67%). We identified four groups of women with distinct patterns of adherence: (1) high (i.e., ≥6 doses per week) steady adherence throughout follow-up (22% of PrEP initiators); (2) moderate (i.e., 4-5 doses per week), but steady adherence (31%); (3) initially high, but consistently declining adherence (21%); and (4) initially moderate adherence, followed by a rapid decline and subsequent rebound (26%). In multivariable-adjusted analyses, older age was associated with membership in the high, steady adherence group as compared to the group identified with an adherence trajectory of initially high, then decline, and finally a rebound. Conclusions: GBTM is useful for exploring potential heterogeneity in longitudinal patterns of medication adherence. Although a large proportion of women in this study achieved high levels of adherence by electronic pillcap initially, far fewer women maintained these levels consistently. Knowledge of different adherence trajectories could be used to develop targeted strategies for optimizing HIV prevention during periconception.

Indexed as

adherencegroup-based trajectory modeling (GBTM)HIV preventionoral pre-exposure prophylaxis (PrEP)periconceptionwomen

Identifiers

PMID37860779
PMCPMC10582627
OpenAlexW4387335818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.